RecruitingNot ApplicableNCT07064798

Cryocompression for CIPN

Evaluating the Use of Limb Cryocompression to Reduce Taxane-induced Peripheral Neuropathy

Sponsor

Dana-Farber Cancer Institute

Enrollment

50 participants

Start Date

Oct 22, 2025

Study Type

INTERVENTIONAL

Conditions

Chemotherapy Induced Peripheral Neuropathy Taxane-induced Peripheral Neuropathy CIPN - Chemotherapy-Induced Peripheral Neuropathy

Summary

This study aims to evaluate the effectiveness, tolerability, and safety of using cooling therapy and pressure (cryocompression) to reduce peripheral neuropathy, a condition affecting the nerves supplying the arms and legs (limbs) resulting in possible numbness, pain, and/or loss of motor function, that may occur as a result of taxane-based chemotherapy. The name of the device used in this research study is: -Paxman Limb Cryocompression System (PLCS)

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Paxman Limb Cryocompression System for people with cipn - chemotherapy-induced peripheral neuropathy, chemotherapy induced peripheral neuropathy, and other related conditions. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEPaxman Limb Cryocompression System

An investigational device designed to provide controlled cooling and compression to participant limbs during chemotherapy administration. The device is comprised of a control unit, connecting hose, and two limb wraps. The customizable limb wraps delivers continuous-flow cooling-and-compression to participant extremities